ADVI Director, Lindsay Bealor Greenleaf, talked with CNBC about the Administration’s proposed rule on rebates and what it could mean for drug prices and PBMs
"The market consolidation that we've seen with pharmacy benefits managers makes it harder for manufacturers to push back against this demand for rebates" explained Lindsay Bealor Greenleaf, a director at ADVI Health, a health care policy consultancy.
[el-text]
Written by Bertha Coombs and Christine Wang
***excerpt***
“The market consolidation that we’ve seen with pharmacy benefits managers makes it harder for manufacturers to push back against this demand for rebates” explained Lindsay Bealor Greenleaf, a director at ADVI Health, a health care policy consultancy.
***end excerpt***
***
[/el-text]
View full article here
Reach out
Own your edge
We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.